Study in Patients With Asthma

Completed · Phase 2

Conditions studied: Asthma

In brief

The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.

Key facts

Study ID

NCT00215397

Run by

Dey

People needed

16

Expected to finish

2005-12-01

Last updated by the study team

2010-11-11

Who can join

Age: 5 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a history of asthma

You may not qualify if…

• Current asthma exacerbation or recent asthma exacerbation, requiring hospitalization
• History of smoking
• Debilitating systemic and/or life-threatening diseases.

Where it is running

• Research Site — Long Beach, California, United States
• Research Site — Denver, Colorado, United States
• Research Site — Medford, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.